Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Purple Biotech Ltd. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $18.50M | $18.50M - $18.50M | $11.10M | -$0.29 | 1 |
| Dec 2029 | $33.00M | $33.00M - $33.00M | $19.80M | $0.07 | 1 |
| Dec 2028 | $6.50M | $6.50M - $6.50M | $3.90M | -$0.15 | 1 |
| Dec 2027 | $36.40M | $36.40M - $36.40M | $21.84M | -$0.88 | 1 |
| Dec 2026 | $7.70M | $7.70M - $7.70M | $4.62M | -$5.31 | 1 |
| Dec 2025 | $0.00 | $0.00 - $0.00 | $0.00 | -$12.20 | 0 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$8.30 | 0 |
| Dec 2021 | $10.20M | $10.20M - $10.20M | $2.04M | -$1.00 | 1 |
| Dec 2020 | $4.70M | $4.70M - $4.70M | $940.0K | -$0.80 | 1 |
| Dec 2019 | $5.41M | $5.41M - $5.41M | $1.08M | -$92.00 | 1 |
| Dec 2018 | $607.0K | $607.0K - $607.0K | $121.4K | -$6.00 | 1 |